Tag:

Manufacturing Deals

Latest Headlines

Latest Headlines

Merck, MedImmune deal space

Capacity issues have led to a facility relationship deal between MedImmune and Merck ( $MRK ). The former will provide space in its Frederick, MD, facility for bulk product manufacturing by the latter.

SCM flexes formulation muscle for Mitovie

U.K.-based SCM Pharma is launching a formulation development capability in a deal with the University of Sunderland. SCM Pharma's move follows a two-year development project with Mitovie Pharma

Dairy JV nabs India's excipients maker Brahmar

DMV-Fonterra Excipients (DFE), a joint venture pairing two large dairy groups, has struck a deal to acquire India's Brahmar Cellulose in a bid to become the primary go-to supplier of lactose

Disposables maker PBS takes run at Pall, Sartorius

Single-use technology provider PBS Biotech has acquired Integrity CMI, a manufacturing company that designs, tests and packages medical device and biotech products. PBS says it will integrate CMI

HealthSport buys SMI assets

Dissolvable thin-film product formulator HealthSport is branching into the natural products market. It's acquiring certain operating assets of SMI Manufacturing, including the lease of the

P&G/Teva manufacturing savvy threatens J&J

Procter & Gamble's plan to ride Teva's manufacturing expertise shows just how valuable a manufacturing operation can be. That's not to say that the ops boost for P&G is the essence of the

International troika drives biomanufacturing platforms

GE Healthcare has teamed with Sweden's iBio and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine manufacturing gear. The arrangement capitalizes on GE's global life

Genzyme re-ups and beefs up business with Hospira for fill/finish ops

Genzyme will have Hospira conduct the final steps of manufacturing for a growing list of drugs under a new supply agreement. Hospira will provide fill/finish services for Cerezyme, Fabrazyme,

Itero finds synergy in Xcellerex

The combination of disposable technology, contract manufacturing capabilities, and a development partner has led specialty biopharma Itero, in San Mateo, CA, to join forces with opposite-coast